HCID 178467881, 화합물 → HCID 178461152, 화합물

HRID 990590

반응식

HRID 990590 반응식
CCO.[CH3:4][C@@H:5]1[C@@H:19]2[C:14](=[C:15]([OH:34])[C@:16]3([OH:33])[C:24](=[O:25])[C:23]([C:26]([NH2:28])=[O:27])=[C:22]([OH:29])[C@@H:21]([N:30]([CH3:32])[CH3:31])[C@@H:17]3[C@H:18]2[OH:20])[C:12](=[O:13])[C:11]2[C:10]([OH:35])=[CH:9][CH:8]=[CH:7][C:6]1=2.O.Cl>CN1CCCC1=O>[CH3:4][C@@H:5]1[C@@H:19]2[C:14](=[C:15]([OH:34])[C@:16]3([OH:33])[C:24](=[O:25])[C:23]([C:26]([NH2:28])=[O:27])=[C:22]([OH:29])[C@@H:21]([N:30]([CH3:31])[CH3:32])[C@@H:17]3[C@H:18]2[OH:20])[C:12](=[O:13])[C:11]2[C:10]([OH:35])=[CH:9][CH:8]=[CH:7][C:6]1=2

참가 물질

3

실험 절차

The biodegradable polymer of the present invention dissolved in N-methyl pyrollidone was loaded into a 1 ml syringe. Doxycycline hyclate was loaded into another 1 ml syringe to give a drug load of 8.5 percent doxycycline. The syringes were coupled together and mixed for 50 cycles. The syringe was then placed on a scale and tared. The composition containing doxycycline was then dropped into 5 ml phosphate buffer solution at a pH of 7.40 and a temperature of 37° C. The syringe was then placed back on the scale and the implant weight was recorded. This was repeated for each formulation four more times to give an n of five at each time point. The samples were then placed in an environmental shaker at 37° C. with a speed of 150 RPMs. At various time points, the phosphate buffer solution was decanted and the polymer implant was left in the vial. A fresh 5 ml of phosphate buffer solution was added to the precipitated polymer and placed back in the shaker. The phosphate buffer solution that was decanted was then analyzed by UV visibility for doxycycline content. Based upon the implant weight a theoretical amount of doxycycline was calculated. Drug release was then based upon this theoretical amount. Release data are depicted FIG. 4.

후처리

  1. customwas loaded into a 1 ml syringe

출처 및 근거

ORD 기록
ord-cdaa262b5d964b5fbcc99d69bfd3abf2
출처 데이터셋
uspto-grants-2002_10
특허 번호
US06461631B1

연결된 노트

불러오는 중…